Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 11Neoplasms 5Stomach Neoplasms 2Small Cell Lung Carcinoma 2Ovarian Neoplasms 2Metastatic Pancreatic Adenocarcinoma 2Head and Neck Neoplasms 2Glioma 2Colorectal Neoplasms 2Biliary Tract Neoplasms 2Weight Loss 1Triple Negative Breast Neoplasms 1Solid Tumor 1Refractory Solid Tumors 1Pseudomyxoma Peritonei 1Pancreatic cancer, adult 1Pancreatic Diseases 1Oligodendroglioma 1Neoplasms, Cystic, Mucinous, and Serous 1Metastatic Adenocarcinoma of the Pancreas 1Mesothelioma 1Malignant Solid Neoplasm 1Locally Advanced Rectal Cancer (LARC) 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Gliosarcoma 1Glioblastoma 1Fallopian Tube Neoplasms 1Endocrine Gland Neoplasms 1Disease 1Digestive System Neoplasms 1

Interventions

irinotecan sucrosofate 1Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Locally Advanced Rectal Cancer (LARC) × irinotecan sucrosofate × Clear all
NCT04009876 2022-12-13

A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer

Fundación de investigación HM

Phase 2 Completed
30 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡